> ## Content Index
> Fetch the complete content index at: https://www.sanarelab.science/llms.txt
> Use this file to discover other available public pages before exploring further.

# Mebendazole Blocks a Cancer-Fueling Import Gate in Cells, Structure Study Shows
- URL: https://www.sanarelab.science/mebendazole-octn1-inhibitor-cervical-lung-cancer-cells-2026/
- Published: 2026-10-16T08:15:28.000Z
- Updated: 2026-10-16T08:15:28.000Z
- Description: Cryo-EM structures of the OCTN1 transporter plus virtual screening identified mebendazole as a potent OCTN1 inhibitor; it suppressed proliferation of cervical and lung cancer cells in vitro. Preclinical — cells only, no animal or patient data yet.
- Author: Sanare Lab
- Tags: #short-read, News, Research, mebendazole

Key Takeaway

Scientists mapped a cellular "import gate" called OCTN1 atom by atom, then used the map to find drugs that jam it — and the anti-parasite pill mebendazole turned out to block it strongly. In lab dishes, mebendazole slowed the growth of cervical and lung cancer cells.

Every cell has transporters — gates in its outer membrane that import nutrients. One of them, OCTN1, imports ergothioneine (an antioxidant made by fungi that our cells hoard) and can also carry acetylcholine, a signaling chemical that — outside the nervous system — helps tumors grow and invade. Overactive OCTN1 has been linked to cancer progression.

The team solved cryo-EM structures of human OCTN1 — cryo-EM is a technique that photographs frozen proteins down to near-atomic detail — showing exactly where ergothioneine binds and how the gate moves as it works. Using that map, they ran a virtual screen (computer testing of drug structures against the binding site) and identified mebendazole, a cheap decades-old deworming drug, as a potent OCTN1 blocker. In cell cultures, mebendazole suppressed the proliferation — the division and multiplication — of cervical and lung cancer cells.

The catch: this was done in dishes, not in animals or patients, and the abstract gives no potency numbers. Blocking a transporter in a dish does not mean the drug will reach tumors in the body at useful doses. For the bigger picture, see [our review of 22 mebendazole brain-tumor studies](https://www.sanarelab.science/mebendazole-brain-tumor-systematic-review-2026/) and [why mebendazole interests cancer researchers](https://www.sanarelab.science/mebendazole-glioblastoma-brain-tumor-2025/); dosing questions: our [dosing calculator](https://www.sanarelab.science/protocol-dosing-workspace/).

## In plain words

**What happened:** Researchers took atom-level pictures of a cell's import gate and then searched for medicines that fit its lock. Mebendazole, a common deworming pill, fit — and slowed cervical and lung cancer cells growing in dishes.

**Why it matters:** This gate can feed tumors a growth signal. If a cheap, well-known pill can jam it, doctors might one day have a new tool — that is why the finding matters.

**How strong is the evidence:** Very early: protein structures plus cancer cells in lab dishes. No animals, no patients, and no potency numbers were reported in the summary — promising, not proven.

**What it means for you:** Nothing changes for treatment today. Do not self-medicate with mebendazole — it is a prescription drug. If you have cancer, ask your oncologist about clinical trials.

## References

1. Structural and mechanistic insights into OCTN1-mediated transport and cancer cell proliferation (preclinical — protein structures and cell cultures, not yet tested in animals or patients). *Nature Communications*. 2026 Sep 14\. [doi:10.1038/s41467-026-77727-2](https://doi.org/10.1038/s41467-026-77727-2?ref=sanarelab.science). [PMID: 42875455](https://pubmed.ncbi.nlm.nih.gov/42875455/?ref=sanarelab.science).

## Medical Disclaimer

This article is informational, not medical advice. Research in cells cannot predict effects in people. Never change medication without consulting your doctor.